Human EGFR gene mutation site T790M detection reagent and detection method
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- WENZHOU MEDICAL UNIV
- Publication Date
- 2019-10-25
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of detection of human EGFR gene mutation site p.T790M (c.2369C>T), in particular to PCR technology and single-base extension reaction, combined with magnetic particle technology, to realize the trace detection of p.T790M. Background technique
[0002] EGFR is a glycoprotein receptor on the surface of the cell membrane, has tyrosine kinase (Tyrosine Kinase, TK) activity, and is the expression product of the proto-oncogene c-erbB-1 (HER-1). The main signal transduction pathways of EGFR are: PI3K-PDK pathway, RAS-RAF-MEK-ERK-MAPK pathway, PLC-γ pathway, JAK-STAT pathway. Through these pathways, extracellular signals are converted into intracellular signals, thereby effectively responding to external signal stimuli, regulating cell growth, proliferation, differentiation, and inhibiting cell apoptosis.
[0003] In 2003, the U.S. Food and Drug Administration (FDA) approved AstraZeneca's EGFR small-molecule tar...